|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
Statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Esteva FJ, Hubbard-Lucey VM, Tang J and
Pusztai L: Immunotherapy and targeted therapy combinations in
metastatic breast cancer. Lancet Oncol. 20:e175–e186. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Stehle G, Sinn H, Wunder A, Schrenk HH,
Stewart JC, Hartung G, Maier-Borst W and Heene DL: Plasma protein
(albumin) catabolism by the tumor itself-implications for tumor
metabolism and the genesis of cachexia. Crit Rev Oncol Hematol.
26:77–100. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Coates RJ, Clark WS, Eley JW, Greenberg
RS, Huguley CM Jr and Brown RL: Race, nutritional status, and
survival from breast cancer. J Natl Cancer Inst. 82:1684–1692.
1990. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cohen MP: Clinical, pathophysiological and
structure/function consequences of modification of albumin by
Amadori-glucose adducts. Biochim Biophys Acta. 1830:5480–5485.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hoogenboezem EN and Duvall CL: Harnessing
albumin as a carrier for cancer therapies. Adv Drug Deliv Rev.
130:73–89. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lee JL, Oh ES, Lee RW and Finucane TE:
Serum albumin and prealbumin in calorically restricted, nondiseased
individuals: A systematic review. Am J Med. 128:1023e1–22. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liu Z and Chen X: Simple bioconjugate
chemistry serves great clinical advances: Albumin as a versatile
platform for diagnosis and precision therapy. Chem Soc Rev.
45:1432–1456. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Selfridge JM, Sinner HF, Whiting J, Sun W,
Mallory MA, Hoover SJ, Kiluk JV, Khakpour N, Czerniecki BJ, Laronga
C, et al: Effect of microporous polysaccharide particles in
patients undergoing mastectomy. Clin Breast Cancer.
S1526-8209(22)00177-X 2022 (Epub ahead of print). PubMed/NCBI
|
|
10
|
Wu S, Xin Z, Sui D, Ou Z, Bai H, Zhu S,
Wang X and Zhang J: Development and validation of a nomogram to
predict drainage duration in patients with breast cancer treated
with modified radical mastectomy. Sci Rep. 11:25332021. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Latorre A, Latorre A, Castellanos M,
Rodriguez Diaz C, Lazaro-Carrillo A, Aguado T, Lecea M,
Romero-Pérez S, Calero M, Sanchez-Puelles JM, et al:
Multifunctional albumin-stabilized gold nanoclusters for the
reduction of cancer stem cells. Cancers (Basel). 11:9692019.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mantovani A: The yin-yang of
tumor-associated neutrophils. Cancer Cell. 16:173–174. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Todoric J and Karin M: The Fire within:
Cell-Autonomous Mechanisms in Inflammation-Driven Cancer. Cancer
Cell. 35:714–720. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yang L and Lin PC: Mechanisms that drive
inflammatory tumor microenvironment, tumor heterogeneity, and
metastatic progression. Semin Cancer Biol. 47:185–195. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Glennon-Alty L, Hackett AP, Chapman EA and
Wright HL: Neutrophils and redox stress in the pathogenesis of
autoimmune disease. Free Radic Biol Med. 125:25–35. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Aiyappa-Maudsley R, Elsalem L, Ibrahim
AIM, Pors K and Martin SG: In vitro radiosensitization of breast
cancer with hypoxia-activated prodrugs. J Cell Mol Med.
26:4577–4590. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ramirez-Moreno IG, Ibarra-Sanchez A,
Castillo-Arellano JI, Blank U and Gonzalez-Espinosa C: Mast cells
localize in hypoxic zones of tumors and secrete CCL-2 under Hypoxia
through Activation of L-type calcium channels. J Immunol.
204:1056–1068. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kong B, Li M, Gao B, Han B, Zhao Z and
Wang F: Retracted Article: Overexpression of circ_0034642
contributes to hypoxia-induced glycolysis, cell proliferation,
migration and invasion in gliomas by facilitating TAGLN2 expression
via sponging miR-625-5p. RSC Adv. 10:897–908. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ding Y and Xue L: The potential value of
fibrinogen to albumin ratio (FAR) in the assessment of inflammation
in spondyloarthritis. BMC Musculoskelet Disord. 23:8642022.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hara K, Aoyama T, Yamada T, Nakazono M,
Nagasawa S, Shimoda Y, Kumazu Y, Numata M, Hayashi T, Tamagawa H,
et al: The prognostic value of the perioperative systemic
inflammation score for patients with advanced gastric cancer.
Anticancer Res. 40:1503–1512. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ikeguchi M, Hanaki T, Endo K, Suzuki K,
Nakamura S, Sawata T and Shimizu T: C-Reactive Protein/albumin
ratio and prognostic nutritional index are strong prognostic
indicators of survival in resected pancreatic ductal
adenocarcinoma. J Pancreat Cancer. 3:31–36. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Artigas A, Wernerman J, Arroyo V, Vincent
JL and Levy M: Role of albumin in diseases associated with severe
systemic inflammation: Pathophysiologic and clinical evidence in
sepsis and in decompensated cirrhosis. J Crit Care. 33:62–70. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Don BR and Kaysen G: Serum albumin:
Relationship to inflammation and nutrition. Semin Dial. 17:432–437.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Frye S, Butterfield R and Hoffman JM:
SNMMI clinical trials network research series for technologists:
Ethical issues and regulations in the medical workplace. J Nucl Med
Technol. 49:303–310. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Morote J, Aguilar A, Planas J and Trilla
E: Definition of castrate resistant prostate cancer: New Insights.
Biomedicines. 10:6892022. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chinese Association of Breast Surgery, . A
consensus statement on the breast-conserving surgery of early-stage
breast cancer (2019). Zhonghua Wai Ke Za Zhi. 57:81–84. 2019.(In
Chinese). PubMed/NCBI
|
|
27
|
Kim H: Propensity score analysis in
non-randomized experimental designs: An overview and a tutorial
using R software. New Dir Child Adolesc Dev. 2019:65–89. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhou ZR, Wang WW, Li Y, Jin KR, Wang XY,
Wang ZW, Chen YS, Wang SJ, Hu J, Zhang HN, et al: In-depth mining
of clinical data: The construction of clinical prediction model
with R. Ann Transl Med. 7:7962019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sarett SM, Werfel TA, Lee L, Jackson MA,
Kilchrist KV, Brantley-Sieders D and Duvall CL: Lipophilic siRNA
targets albumin in situ and promotes bioavailability, tumor
penetration, and carrier-free gene silencing. Proc Natl Acad Sci
USA. 114:E6490–E6497. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang X. Han H, Duan Q, Khan U, Hu Y and
Yao X: Changes of serum albumin level and systemic inflammatory
response in inoperable non-small cell lung cancer patients after
chemotherapy. J Cancer Res Ther. 10:1019–1023. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bozzetti F, Migliavacca S, Scotti A,
Bonalumi MG, Scarpa D, Baticci F, Ammatuna M, Pupa A, Terno G,
Sequeira C, et al: Impact of cancer, type, site, stage and
treatment on the nutritional status of patients. Ann Surg.
196:170–179. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chen J, Zhou Y, Xu Y, Zhu HY and Shi YQ:
Low pretreatment serum globulin may predict favorable prognosis for
gastric cancer patients. Tumour Biol. 37:3905–3911. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liu X, Meng QH, Ye Y, Hildebrandt MA, Gu J
and Wu X: Prognostic significance of pretreatment serum levels of
albumin, LDH and total bilirubin in patients with non-metastatic
breast cancer. Carcinogenesis. 36:243–248. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lis CG, Grutsch JF, Vashi PG and
Lammersfeld CA: Is serum albumin an independent predictor of
survival in patients with breast cancer? JPEN J Parenter Enteral
Nutr. 27:10–15. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Mantovani A: The inflammation-cancer
connection. FEBS J. 285:638–640. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Sun H, Hu P, Shen H, Dong W, Zhang T, Liu
Q and Du J: Albumin and neutrophil combined prognostic grade as a
new prognostic factor in non-small cell lung cancer: Results from a
large consecutive cohort. PLoS One. 10:e01446632015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Dumitru CA, Lang S and Brandau S:
Modulation of neutrophil granulocytes in the tumor
microenvironment: Mechanisms and consequences for tumor
progression. Semin Cancer Biol. 23:141–148. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Dumitru CA, Gholaman H, Trellakis S,
Bruderek K, Dominas N, Gu X, Bankfalvi A, Whiteside TL, Lang S and
Brandau S: Tumor-derived macrophage migration inhibitory factor
modulates the biology of head and neck cancer cells via neutrophil
activation. Int J Cancer. 129:859–869. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kaplan MJ and Radic M: Neutrophil
extracellular traps: Double-edged swords of innate immunity. J
Immunol. 189:2689–2695. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Manzo A, Sforza V, Carillio G, Palumbo G,
Montanino A, Sandomenico C, Costanzo R, Esposito G, Laudato F,
Mercadante E, et al: Lurbinectedin in small cell lung cancer. Front
Oncol. 12:9321052022. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Yang ZY, Liu L, Mao C, Wu XY, Huang YF, Hu
XF and Tang JL: Chemotherapy with cetuximab versus chemotherapy
alone for chemotherapy-naive advanced non-small cell lung cancer.
Cochrane Database Syst Rev CD009948, . 2014. View Article : Google Scholar
|
|
42
|
Mhaskar R, Clark OA, Lyman G, Engel Ayer
Botrel T, Morganti Paladini L and Djulbegovic B: Colony-stimulating
factors for chemotherapy-induced febrile neutropenia. Cochrane
Database Syst Rev. 2014:CD0030392014.PubMed/NCBI
|
|
43
|
Qu N, Sun Y, Li Y, Hao F, Qiu P, Teng L,
Xie J and Gao Y: Docetaxel-loaded human serum albumin (HSA)
nanoparticles: Synthesis, characterization, and evaluation. Biomed
Eng Online. 18:112019. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Huang J, Wu B, Zhou Z, Hu S, Xu H, Piao Y,
Zheng H, Tang J, Liu X and Shen Y: Drug-binding albumins forming
stabilized nanoparticles for efficient anticancer therapy.
Nanomedicine. 21:1020582019. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Hawkins MJ, Soon-Shiong P and Desai N:
Protein nanoparticles as drug carriers in clinical medicine. Adv
Drug Deliv Rev. 60:876–885. 2008. View Article : Google Scholar : PubMed/NCBI
|
